X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA NATCO PHARMA SHASUN PHARMA/
NATCO PHARMA
 
P/E (TTM) x 123.9 19.0 651.3% View Chart
P/BV x 8.5 18.2 46.8% View Chart
Dividend Yield % 0.2 0.6 37.1%  

Financials

 SHASUN PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
NATCO PHARMA
Mar-14
SHASUN PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs94877 10.7%   
Low Rs46424 10.8%   
Sales per share (Unadj.) Rs214.2223.4 95.9%  
Earnings per share (Unadj.) Rs5.331.1 17.2%  
Cash flow per share (Unadj.) Rs15.840.3 39.3%  
Dividends per share (Unadj.) Rs1.005.00 20.0%  
Dividend yield (eoy) %1.40.8 186.1%  
Book value per share (Unadj.) Rs53.3219.5 24.3%  
Shares outstanding (eoy) m56.6233.07 171.2%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x0.32.9 11.2%   
Avg P/E ratio x13.120.9 62.6%  
P/CF ratio (eoy) x4.416.1 27.4%  
Price / Book Value ratio x1.33.0 44.2%  
Dividend payout %18.716.1 116.4%   
Avg Mkt Cap Rs m3,95821,504 18.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1641,128 191.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1277,389 164.1%  
Other income Rs m229167 137.3%   
Total revenues Rs m12,3567,556 163.5%   
Gross profit Rs m1,0091,793 56.3%  
Depreciation Rs m594304 195.0%   
Interest Rs m415366 113.4%   
Profit before tax Rs m2301,290 17.8%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73309 -23.6%   
Profit after tax Rs m3021,027 29.4%  
Gross profit margin %8.324.3 34.3%  
Effective tax rate %-31.723.9 -132.3%   
Net profit margin %2.513.9 17.9%  
BALANCE SHEET DATA
Current assets Rs m6,8843,681 187.0%   
Current liabilities Rs m8,4563,123 270.8%   
Net working cap to sales %-13.07.6 -171.4%  
Current ratio x0.81.2 69.1%  
Inventory Days Days6289 68.9%  
Debtors Days Days10859 183.3%  
Net fixed assets Rs m4,9707,685 64.7%   
Share capital Rs m113331 34.3%   
"Free" reserves Rs m2,8756,670 43.1%   
Net worth Rs m3,0207,259 41.6%   
Long term debt Rs m1,817955 190.3%   
Total assets Rs m13,34711,957 111.6%  
Interest coverage x1.64.5 34.4%   
Debt to equity ratio x0.60.1 457.4%  
Sales to assets ratio x0.90.6 147.0%   
Return on assets %5.411.7 46.1%  
Return on equity %10.014.2 70.7%  
Return on capital %13.320.7 64.3%  
Exports to sales %46.439.4 117.8%   
Imports to sales %14.25.7 249.9%   
Exports (fob) Rs m5,6222,908 193.3%   
Imports (cif) Rs m1,728421 410.2%   
Fx inflow Rs m5,8433,445 169.6%   
Fx outflow Rs m2,173703 309.2%   
Net fx Rs m3,6692,743 133.8%   
CASH FLOW
From Operations Rs m3981,440 27.6%  
From Investments Rs m-1,635-1,089 150.1%  
From Financial Activity Rs m1,309-353 -371.0%  
Net Cashflow Rs m71-1 -4,778.5%  

Share Holding

Indian Promoters % 39.2 52.0 75.3%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 3.6 7.8 45.9%  
FIIs % 17.6 16.6 105.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.0 152.3%  
Shareholders   20,750 25,395 81.7%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Lower; Healthcare Stocks Witness Selling(09:30 am)

Asian shares are trading on a mixed note today. The Nikkei 225 is up 1.8% while the Hang Seng is down 0.2%. The Shanghai Composite is trading down by 0.5%.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6%

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Has A Bank Ever Told You Its Deposits are Riskier than Stocks? These Should Have...(The 5 Minute Wrapup)

Jul 3, 2018

Left on their own, the banks would possibly have to mark down the value of deposits by 90% to 100%.

The Real Truth About India's FDI, Beyond WhatsApp(Vivek Kaul's Diary)

Jul 4, 2018

The FDI numbers do not look very impressive once we adjust for repatriations as well as the overall growth in the economy.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - BIOCON LTD COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS